Stock listing
Hyphens Pharma International Ltd.
Selected listing: 1J5 · SGX · SGD · SG
Hyphens Pharma International Ltd. (SGX:1J5), Health Technology. Latest release Jan 5, 2026: Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream…
- Ticker
- SGX:1J5
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SGX
- Currency
- SGD
About Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. is a public company listed on the Singapore Exchange under the ticker 1J5. Hyphens Pharma focuses on providing healthcare and pharmaceutical solutions in the region.
Latest news from Hyphens Pharma International Ltd.
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
January 5, 2026
Cosmo Announces Launch of Winlevi(R) for Treatment of Acne in Singapore and Malaysia
July 17, 2025
Hyphens Pharma licenses Wynzora Cream for ASEAN countries from MC2 Therapeutics
March 13, 2024
General Announcement::HYPHENS PHARMA HAS INKED EXCLUSIVE LICENSING DEAL OF USTEKINUMAB BIOSIMILAR
December 13, 2021
Asset Acquisitions and Disposals::STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD
December 9, 2021
Research Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. company profile
View the public company page for Hyphens Pharma International Ltd. on 6ix.
Hyphens Pharma International Ltd. news
Read company news and market updates connected to Hyphens Pharma International Ltd..
Hyphens Pharma International Ltd. investor events
Find investor webinars, events, and replay context for Hyphens Pharma International Ltd..